Join the 'Mycobacterium avium-intracellulare - Treatment' group to help and get support from people like you.
Mycobacterium avium-intracellulare - Treatment News
Posted 1 Oct 2018 by Drugs.com
MONDAY, Oct. 1, 2018 – Arikayce has been approved by the U.S. Food and Drug Administration to treat lung disease caused by Mycobacterium avium complex (MAC) bacteria among people who don't respond to conventional therapies, the FDA said in a news release. MAC bacteria are commonly found in water and soil. Symptoms of MAC-triggered lung disease include chronic cough, fatigue, weight loss, night ...
FDA Approves Arikayce (amikacin liposome inhalation suspension) to treat Mycobacterium Avium Complex (MAC) Lung Disease
Posted 29 Sep 2018 by Drugs.com
September 28, 2018 – The U.S. Food and Drug Administration today approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment (refractory disease). MAC is a type of nontuberculous ...
Posted 1 Jul 2015 by Drugs.com
WEDNESDAY, July 1, 2015 – Even after the advent of powerful medications for suppressing HIV, a new study finds that more than one-third of people in San Francisco who were diagnosed with an AIDS-related infection died within five years. "The main cause of mortality arises from people stopping treatment entirely," said Dr. Robert Grant, a professor at the University of California, San Francisco, ...
Related Condition Support Groups
Related Drug Support Groups
azithromycin, Cipro, ciprofloxacin, Zithromax, clarithromycin, Biaxin, rifampin, ofloxacin, ethambutol, view more... Biaxin XL, streptomycin, Azithromycin Dose Pack, Floxin, Arikayce, amikacin liposome, rifabutin, Myambutol, Cipro IV, Mycobutin, Zmax, Floxin IV, Cipro XR